Latest / Connected With Latham
Episode 109 – Drug Pricing and Market Access: Key Takeaways From 2025 and Outlook for 2026
The drug pricing and market access policy space saw a lot of change in 2025, and the pace is not slowing down. In this episode of Connected With Latham, pharmaceutical industry veteran Sabrina Aery, founder of Aery Policy and Access Partners, joins Washington, D.C. partner Chris Schott and associate Danny Machado for a wide-ranging discussion of key 2025 takeaways and what to expect in 2026.
Also check out our bi-weekly Drug Pricing Digest on the website or subscribe to receive future editions in your inbox.
This podcast is provided as a service of Latham & Watkins LLP. Listening to this…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.